Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy-Reference-Cited by-同舟云学术

Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy

Published:2016-09 Issue: Volume:116 Page:22-38
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Zhao Chong,Chen Xin,Zang Dan,Lan Xiaoying,Liao Siyan,Yang Changshan,Zhang Peiquan,Wu Jinjie,Li Xiaofen,Liu Ningning,Liao Yuning,Huang Hongbiao,Shi Xianping,Jiang Lili,Liu Xiuhua,He Zhimin,Wang Xuejun,Liu Jinbao

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference45 articles.

1. Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer;Hsu;J. Clin. Oncol.,2007

2. Molecular mechanisms of resistance and toxicity associated with platinating agents;Rabik;Cancer Treat. Rev.,2007

3. Structure, recognition, and processing of cisplatin-DNA adducts;Jamieson;Chem. Rev.,1999

4. Cellular and molecular pharmacology of oxaliplatin;Raymond;Mol. Cancer Ther.,2002

5. A phase 2 study of bortezomib in relapsed, refractory myeloma;Richardson;New Engl. J. Med.,2003

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway;Cell Death & Disease;2024-03-26

2. Targeting deubiquitinases for cancer therapy;Clinical and Translational Discovery;2023-09-12

3. Exploiting the Proteasome for Disease Treatment;Protein Homeostasis in Drug Discovery;2022-11-14

4. USP14: Structure, Function, and Target Inhibition;Frontiers in Pharmacology;2022-01-05

5. Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment;Acta Pharmacologica Sinica;2021-12-10